A Review of Accelerator-Produced Ga-68 with Solid Targets

Area of Science:

• Nuclear Medicine
• Radiochemistry
• Accelerator Physics

Background:

• Gallium-68 (Ga-68) is a key positron-emitting radionuclide for Positron Emission Tomography (PET) imaging.
• Its clinical use is expanding in theranostic applications, particularly with lutetium-177 (Lu-177) radiopharmaceuticals.
• Germanium-68/Gallium-68 (Ge-68/Ga-68) generators are the primary source, but accelerator production is emerging.

Purpose of the Study:

• To review and compare different strategies for accelerator-based production of Ga-68.
• To assess the feasibility and implications of various production techniques for clinical radiolabeling.

Main Methods:

• Discussion of accelerator targetry, including beam energy and intensity considerations.
• Overview of radiochemical separation techniques for isolating Ga-68 from irradiated targets.
• Analysis of isotopically enriched target material recovery methods.

Main Results:

• Accelerator production offers an alternative to generator-based Ga-68.
• Different accelerator parameters and separation methods impact Ga-68 yield and purity.
• Optimized production strategies are crucial for efficient downstream radiolabeling.

Conclusions:

• Accelerator-based production of Ga-68 presents a viable and potentially scalable alternative.
• Further research into targetry, separation, and recovery is needed to optimize clinical integration.
• Advancements in Ga-68 production will support the growth of theranostic nuclear medicine.